These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 23740390)
1. Can we predict blood brain barrier permeability of ligands using computational approaches? Kumar R; Sharma A; Tiwari RK Interdiscip Sci; 2013 Jun; 5(2):95-101. PubMed ID: 23740390 [TBL] [Abstract][Full Text] [Related]
2. Prediction of Central Nervous System Side Effects Through Drug Permeability to Blood-Brain Barrier and Recommendation Algorithm. Fan J; Yang J; Jiang Z J Comput Biol; 2018 Apr; 25(4):435-443. PubMed ID: 29058464 [TBL] [Abstract][Full Text] [Related]
3. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis. Vucicevic J; Nikolic K; Dobričić V; Agbaba D Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610 [TBL] [Abstract][Full Text] [Related]
4. Current State and Future Perspectives in QSAR Models to Predict Blood- Brain Barrier Penetration in Central Nervous System Drug R&D. Morales JF; Montoto SS; Fagiolino P; Ruiz ME Mini Rev Med Chem; 2017; 17(3):247-257. PubMed ID: 27739359 [TBL] [Abstract][Full Text] [Related]
5. Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications. Gao Z; Chen Y; Cai X; Xu R Bioinformatics; 2017 Mar; 33(6):901-908. PubMed ID: 27993785 [TBL] [Abstract][Full Text] [Related]
6. In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation. Zhang X; Liu T; Fan X; Ai N J Mol Graph Model; 2017 Aug; 75():347-354. PubMed ID: 28628860 [TBL] [Abstract][Full Text] [Related]
7. Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods. Li H; Yap CW; Ung CY; Xue Y; Cao ZW; Chen YZ J Chem Inf Model; 2005; 45(5):1376-84. PubMed ID: 16180914 [TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics. Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782 [TBL] [Abstract][Full Text] [Related]
10. Brain drug targeting: a computational approach for overcoming blood-brain barrier. Mehdipour AR; Hamidi M Drug Discov Today; 2009 Nov; 14(21-22):1030-6. PubMed ID: 19647097 [TBL] [Abstract][Full Text] [Related]
11. In silico prediction of unbound brain-to-plasma concentration ratio using machine learning algorithms. Chen H; Winiwarter S; Fridén M; Antonsson M; Engkvist O J Mol Graph Model; 2011 Aug; 29(8):985-95. PubMed ID: 21571561 [TBL] [Abstract][Full Text] [Related]
12. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine. Jiang L; Chen J; He Y; Zhang Y; Li G J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324 [TBL] [Abstract][Full Text] [Related]
13. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 1. Anti-infective drugs. Adenot M; Perriere N; Scherrmann JM; Lahana R Chemotherapy; 2007; 53(1):70-2. PubMed ID: 17202814 [TBL] [Abstract][Full Text] [Related]
14. Predicting penetration across the blood-brain barrier from simple descriptors and fragmentation schemes. Zhao YH; Abraham MH; Ibrahim A; Fish PV; Cole S; Lewis ML; de Groot MJ; Reynolds DP J Chem Inf Model; 2007; 47(1):170-5. PubMed ID: 17238262 [TBL] [Abstract][Full Text] [Related]
16. Drug delivery and in vitro models of the blood-brain barrier. Cucullo L; Aumayr B; Rapp E; Janigro D Curr Opin Drug Discov Devel; 2005 Jan; 8(1):89-99. PubMed ID: 15679176 [TBL] [Abstract][Full Text] [Related]
17. New experimental models of the blood-brain barrier for CNS drug discovery. Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770 [TBL] [Abstract][Full Text] [Related]
18. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia? Feng S; Huang Y; Chen Z Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042 [TBL] [Abstract][Full Text] [Related]